278 related articles for article (PubMed ID: 25170898)
21. Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation in mice inoculated with tax-deficient adult T-cell leukemia-derived cell lines.
Ohsugi T; Kumasaka T; Okada S; Ishida T; Yamaguchi K; Horie R; Watanabe T; Umezawa K
Cancer Lett; 2007 Nov; 257(2):206-15. PubMed ID: 17764832
[TBL] [Abstract][Full Text] [Related]
22. Involvement of c-Ski oncoprotein in carcinogenesis of cholangiocacinoma induced by Opisthorchis viverrini and N-nitrosodimethylamine.
Boonmars T; Wu Z; Boonjaruspinyo S; Puapairoj A; Kaewsamut B; Nagano I; Pinlaor S; Yongvanit P; Wonkchalee O; Juasook A; Sudsarn P; Srisawangwong T
Pathol Oncol Res; 2011 Jun; 17(2):219-27. PubMed ID: 20853076
[TBL] [Abstract][Full Text] [Related]
23. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
[TBL] [Abstract][Full Text] [Related]
24. Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.
Onori P; DeMorrow S; Gaudio E; Franchitto A; Mancinelli R; Venter J; Kopriva S; Ueno Y; Alvaro D; Savage J; Alpini G; Francis H
Int J Cancer; 2009 Aug; 125(3):565-76. PubMed ID: 19358267
[TBL] [Abstract][Full Text] [Related]
25. Donor pretreatment with DHMEQ improves islet transplantation.
Takahashi T; Matsumoto S; Matsushita M; Kamachi H; Tsuruga Y; Kasai H; Watanabe M; Ozaki M; Furukawa H; Umezawa K; Todo S
J Surg Res; 2010 Sep; 163(1):e23-34. PubMed ID: 20638688
[TBL] [Abstract][Full Text] [Related]
26. Effects of a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines.
Ruan HY; Masuda M; Ito A; Umezawa K; Nakashima T; Yasumatsu R; Kuratomi Y; Yamamoto T; Weinstein IB; Komune S
Head Neck; 2006 Feb; 28(2):158-65. PubMed ID: 16355386
[TBL] [Abstract][Full Text] [Related]
27. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
[TBL] [Abstract][Full Text] [Related]
28. Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.
Thamrongwaranggoon U; Sangkhamanon S; Seubwai W; Saranaruk P; Cha'on U; Wongkham S
In Vivo; 2021; 35(1):267-274. PubMed ID: 33402473
[TBL] [Abstract][Full Text] [Related]
29. Targeting NF-kappaB and induction of apoptosis by novel NF-kappaB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells.
Kimura N; Miyakawa Y; Kohmura K; Umezawa K; Ikeda Y; Kizaki M
Leuk Res; 2007 Nov; 31(11):1529-35. PubMed ID: 17466373
[TBL] [Abstract][Full Text] [Related]
30. Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.
Wu Z; Boonmars T; Nagano I; Loilome W; Yongvanit P; Khuntikeo N; Nielsen PS; Paorojkul C; Takahashi Y; Maekawa Y
Tumour Biol; 2014 Mar; 35(3):1985-95. PubMed ID: 24122204
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V
Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692
[TBL] [Abstract][Full Text] [Related]
32. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.
Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P
Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455
[TBL] [Abstract][Full Text] [Related]
33. Antineoplastic Effects of NF-κB Inhibition by DHMEQ (Dehydroxymethylepoxyquinomicin) Alone and in Co-treatment with Radio-and Chemotherapy in Medulloblastoma Cell Lines.
Ramos PMM; Pezuk JA; Castro-Gamero AM; Oliveira HF; Scrideli CA; Umezawa K; Tone LG
Anticancer Agents Med Chem; 2018; 18(4):541-549. PubMed ID: 29141555
[TBL] [Abstract][Full Text] [Related]
34. PLAU contributes to the development of cholangiocarcinoma via activating NF-κB signaling pathway.
Hu MD; Jia LH; Wang ML
Cell Biol Int; 2023 Aug; 47(8):1381-1391. PubMed ID: 37067236
[TBL] [Abstract][Full Text] [Related]
35. Alteration of galectin-1 during tumorigenesis of Opisthorchis viverrini infection-induced cholangiocarcinoma and its correlation with clinicopathology.
Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Pinlaor S; Pairojkul C; Chamgramol Y; Takahashi Y
Tumour Biol; 2012 Aug; 33(4):1169-78. PubMed ID: 22373585
[TBL] [Abstract][Full Text] [Related]
36. Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway.
Li W; Li M; Su X; Qin L; Miao M; Yu C; Shen Y; Luo Q; Chen Q
Biochimie; 2014 Jun; 101():183-91. PubMed ID: 24486723
[TBL] [Abstract][Full Text] [Related]
37. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.
Yothaisong S; Namwat N; Yongvanit P; Khuntikeo N; Puapairoj A; Jutabha P; Anzai N; Tassaneeyakul W; Tangsucharit P; Loilome W
Parasitol Int; 2017 Aug; 66(4):471-478. PubMed ID: 26657242
[TBL] [Abstract][Full Text] [Related]
38. Induction of apoptosis in Epstein-Barr virus-infected B-lymphocytes by the NF-kappaB inhibitor DHMEQ.
Miyake A; Dewan MZ; Ishida T; Watanabe M; Honda M; Sata T; Yamamoto N; Umezawa K; Watanabe T; Horie R
Microbes Infect; 2008 Jun; 10(7):748-56. PubMed ID: 18538617
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
Raggi C; Taddei ML; Sacco E; Navari N; Correnti M; Piombanti B; Pastore M; Campani C; Pranzini E; Iorio J; Lori G; Lottini T; Peano C; Cibella J; Lewinska M; Andersen JB; di Tommaso L; Viganò L; Di Maira G; Madiai S; Ramazzotti M; Orlandi I; Arcangeli A; Chiarugi P; Marra F
J Hepatol; 2021 Jun; 74(6):1373-1385. PubMed ID: 33484774
[TBL] [Abstract][Full Text] [Related]
40. Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways.
Huang GL; Zhang W; Ren HY; Shen XY; Chen QX; Shen DY
Cancer Sci; 2015 Nov; 106(11):1515-23. PubMed ID: 26310932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
